ACAD
40.55
+0.33
+0.82%
AEMD
8.75
-0.1
-1.13%
APRI
1.56
+0.06
+4.00%
ARNA
4.19
-0.01
-0.24%
ATEC
1.36
+0.01
+0.74%
CNAT
5.36
+0.04
+0.75%
CRXM
0.5
0.00
0.00%
CYTX
0.66
-0.021
-3.0548%
DXCM
68.68
+0.43
+0.63%
GNMK
9.04
+0.01
+0.11%
HALO
17.45
+0.2
+1.16%
ILMN
205
+1.88
+0.93%
INNV
0.153
+0.003
+1.6667%
INO
8.83
+0.57
+6.90%
ISCO
0.05
0.00
0.00%
ISIS
67.76
+0.59
+0.88%
LGND
89.67
+0.44
+0.49%
LPTN
0.305
+0.008
+2.6599%
MBVX
2.29
-0.09
-3.78%
MEIP
1.87
-0.04
-2.09%
MNOV
4.05
+0.05
+1.25%
MRTX
26.81
+0.97
+3.75%
MSTX
0.49
-0.01
-2.97%
NBIX
42.55
+0.57
+1.36%
NUVA
48.25
+0.02
+0.04%
ONCS
0.233
0.00
0.00%
ONVO
4.65
-0.03
-0.64%
OREX
5.01
+0.01
+0.20%
OTIC
24.86
-6.19
-19.94%
QDEL
21.84
-0.89
-3.92%
RCPT
161.65
+1.54
+0.96%
RGLS
12.85
+0.1
+0.78%
RMD
57.08
-0.24
-0.42%
SCIE
0.02
+0.005
+30.2632%
SPHS
0.845
-0.014
-1.630%
SRNE
12.94
-0.27
-2.04%
TROV
10.93
+0.64
+6.22%
VICL
0.926
+0.036
+4.045%
VOLC
17.99
0.00
0.00%
ZGNX
1.4
0.00
0.00%
ACAD
40.55
+0.33
+0.82%
AEMD
8.75
-0.1
-1.13%
APRI
1.56
+0.06
+4.00%
ARNA
4.19
-0.01
-0.24%
ATEC
1.36
+0.01
+0.74%
CNAT
5.36
+0.04
+0.75%
CRXM
0.5
0.00
0.00%
CYTX
0.66
-0.021
-3.0548%
DXCM
68.68
+0.43
+0.63%
GNMK
9.04
+0.01
+0.11%
HALO
17.45
+0.2
+1.16%
ILMN
205
+1.88
+0.93%
INNV
0.153
+0.003
+1.6667%
INO
8.83
+0.57
+6.90%
ISCO
0.05
0.00
0.00%
ISIS
67.76
+0.59
+0.88%
LGND
89.67
+0.44
+0.49%
LPTN
0.305
+0.008
+2.6599%
MBVX
2.29
-0.09
-3.78%
MEIP
1.87
-0.04
-2.09%
MNOV
4.05
+0.05
+1.25%
MRTX
26.81
+0.97
+3.75%
MSTX
0.49
-0.01
-2.97%
NBIX
42.55
+0.57
+1.36%
NUVA
48.25
+0.02
+0.04%
ONCS
0.233
0.00
0.00%
ONVO
4.65
-0.03
-0.64%
OREX
5.01
+0.01
+0.20%
OTIC
24.86
-6.19
-19.94%
QDEL
21.84
-0.89
-3.92%
RCPT
161.65
+1.54
+0.96%
RGLS
12.85
+0.1
+0.78%
RMD
57.08
-0.24
-0.42%
SCIE
0.02
+0.005
+30.2632%
SPHS
0.845
-0.014
-1.630%
SRNE
12.94
-0.27
-2.04%
TROV
10.93
+0.64
+6.22%
VICL
0.926
+0.036
+4.045%
VOLC
17.99
0.00
0.00%
ZGNX
1.4
0.00
0.00%
Home » Archive by Category

Xconomy

West Coast Biotech Roundup: Dendreon, Invitae, Juno, Regulus & More

February 12, 2015 – 1:01 pm

Seattle might be second in professional handegg, but it comes first in this week’s West Coast roundup. The big news is that former high flyer Dendreon is all but sold, with the ever-acquisitive…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Dendreon, Invitae, Juno, Regulus & More

February 12, 2015 – 1:01 pm

Seattle might be second in professional handegg, but it comes first in this week’s West Coast roundup. The big news is that former high flyer Dendreon is all but sold, with the ever-acquisitive…

[[Click headline to continue reading.]]

NIH Opens Discussion: How to Build a U.S. Health Research Database?

February 11, 2015 – 12:27 pm

National Institutes of Health director Francis Collins kicked off a two-day meeting in Bethesda, MD, this morning to discuss how to turn President Obama’s call for a national health research…

[[Click headline to continue reading.]]

NIH Opens Discussion: How to Build a U.S. Health Research Database?

February 11, 2015 – 12:27 pm

National Institutes of Health director Francis Collins kicked off a two-day meeting in Bethesda, MD, this morning to discuss how to turn President Obama’s call for a national health research…

[[Click headline to continue reading.]]

NIH Opens Discussion: How to Build a U.S. Health Research Database?

February 11, 2015 – 12:27 pm

National Institutes of Health director Francis Collins kicked off a two-day meeting in Bethesda, MD, this morning to discuss how to turn President Obama’s call for a national health research…

[[Click headline to continue reading.]]

Cidara’s $42M Series B May Bring Fungal Therapy to Patients

February 11, 2015 – 10:55 am

Cidara Therapeutics grabbed $42 million in a Series B funding round Wednesday to continue developing its treatment for fungal infections, a therapy that it expects will hit the first stage of…

[[Click headline to continue reading.]]

Cidara’s $42M Series B May Bring Fungal Therapy to Patients

February 11, 2015 – 10:55 am

Cidara Therapeutics grabbed $42 million in a Series B funding round Wednesday to continue developing its treatment for fungal infections, a therapy that it expects will hit the first stage of…

[[Click headline to continue reading.]]

Cidara’s $42M Series B May Bring Fungal Therapy to Patients

February 11, 2015 – 10:55 am

Cidara Therapeutics grabbed $42 million in a Series B funding round Wednesday to continue developing its treatment for fungal infections, a therapy that it expects will hit the first stage of…

[[Click headline to continue reading.]]

“21st Century Cures” By Year’s End? Its Backers Want More Ideas

February 9, 2015 – 2:59 pm

If you have an idea to include in the bipartisan initiative known as 21st Century Cures, Fred Upton (R-MI) and Diana DeGette (D-CO) say they are all ears. But speak up quickly: They want to present a…

[[Click headline to continue reading.]]

“21st Century Cures” By Year’s End? Its Backers Want More Ideas

February 9, 2015 – 2:59 pm

If you have an idea to include in the bipartisan initiative known as 21st Century Cures, Fred Upton (R-MI) and Diana DeGette (D-CO) say they are all ears. But speak up quickly: They want to present a…

[[Click headline to continue reading.]]